Key facts
- Notable investors include Buff Gold Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Codebreaker Labs
- ·The full record, as it builds
Funding rounds
No funding rounds for Codebreaker Labs are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Codebreaker Labs
Operator of a synthetic biology platform intended for the generation of causal genomics data at scale. The company's technology generates proprietary causal biological data at scale, revealing how genetic variants, cellular pathways, and drug targets truly function with unmatched resolution, and by shifting from correlation to causation, enabling clinicians and researchers to make faster, data-driven decisions that directly improve patient outcomes.
- Sector
- Healthcare
- HQ
- Boulder, CO, United States
- Founded
- 2025
- Employees
- 3
- Website
- codebreakerlabs.io/
- Ownership
- Privately Held (backing)
Codebreaker Labs doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Codebreaker Labs shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Codebreaker Labs in its N-PORT filings yet. We sweep new filings monthly.